ASCE+ Plus 10 Billion Exosomes for Hair - 20mg

Pack Size: 1 Vial x 20 mg (Lyophilized) | Box of 5 Vials x 20 mg
Manufactured By: ExoCoBio Inc.
Made In: South Korea
Product Type: Lyophilized plant stem cell-derived exosome scalp treatment clinical use
Exosome Count: 10 Billion exosomes per vial
Purpose: Reactivates scalp follicles, reduces hair loss, and supports measurable hair regrowth
Award: IR52 Jang Young-sil Prize 2020 (South Korea's leading innovation award)
Product Name: ExoCoBio ASCE+ HRLV

ExoCoBio ASCE+ HRLV is a premium scalp care solution produced by ExoCoBio Inc., one of South Korea's most recognised exosome research and biotechnology companies. HRLV stands for Hair Regeneration Lyophilized Vial, and that name describes exactly what this product does. Each lyophilized vial carries 10 billion exosomes, freeze-dried to preserve biological activity until the moment of reconstitution and use.

The exosomes in ASCE+ HRLV are derived from plant stem cells through ExoCoBio's proprietary extraction and purification technology. Lyophilization, the same freeze-drying method used in pharmaceutical manufacturing locks in the original potency of the exosomes without the degradation risks that come with liquid-stored formulas. When reconstituted at the time of treatment, the exosomes are released in their most biologically active state, ready to communicate with scalp cells, signal dormant follicles, and begin rebuilding the hair growth environment.

ASCE+ HRLV took home South Korea's IR52 Jang Young-sil Prize in 2020 a national award for technological innovation which reflects the clinical and scientific credibility behind the formula, not just a marketing claim.

Actions

ASCE+ HRLV delivers exosomes directly to the scalp via mesotherapy or microneedling, triggering a chain of biological responses that address hair loss at the follicle and tissue level.

• Delivers 10 billion active exosomes per vial to initiate cell-to-cell signalling across the scalp tissue
• Reactivates dormant and miniaturised follicles by restoring disrupted growth signalling pathways
• Reduces scalp inflammation that silently shortens the active hair growth phase
• Improves microcirculation in the scalp for better oxygen and nutrient delivery to each follicle
• Supports follicle transition from resting (telogen) back into active growth (anagen) phase
• Reduces excessive shedding progressively across a structured treatment course

 

Ingredients

• Plant Stem Cell-Derived Exosomes (10 Billion/vial): Lyophilized biological nano-vesicles that carry growth factors, proteins, and nucleic acids directly into scalp tissue to trigger follicle repair and regeneration
• Growth Factors: Bioactive proteins within the exosome cargo that stimulate follicle activity and support the anagen (growth) phase of the hair cycle
• Lyophilized Carrier Base: Pharmaceutical-grade freeze-dried formulation that preserves full exosome potency until reconstitution at the point of treatment

Benefits of ExoCoBio ASCE+ HRLV

• 10 billion exosomes per vial among the highest concentrations available in clinical scalp therapy
• Lyophilized format preserves biological activity far longer than liquid exosome products
• IR52 Jang Young-sil Prize winner independently validated for technological innovation in Korea
• Targets hair loss at the follicle and scalp environment level, not just the surface
• Effective for male and female pattern hair loss, diffuse thinning, and post-inflammatory alopecia
• Non-surgical, minimally invasive, administered through mesotherapy or microneedling only

How To Use

1. Reconstitute the lyophilized vial with the supplied sterile solution immediately before the session. Do not prepare in advance or store after mixing.
2. Cleanse the patient's scalp thoroughly to remove oil, product residue, and surface debris.
3. Apply topical numbing cream 20–30 minutes before treatment if required by the patient.
4. Administer the reconstituted ASCE+ HRLV into the scalp using a Dermapen, mesotherapy gun, or fine-gauge needle, focusing on thinning zones and areas of active shedding.
5. Apply gentle pressure to treated areas after injection to support even distribution.
6. Recommended course: 4-6 sessions spaced 2-4 weeks apart for optimal follicle response.
7. Advise the patient to avoid scalp washing or heat exposure for at least 12 hours post-treatment.

Safety and Storage

• Store lyophilized vials at 2–8°C cold chain must be maintained throughout storage and delivery
• Do not freeze; extreme cold degrades exosome integrity
• Reconstitute only at the time of treatment do not store after mixing
• Keep all vials out of reach of children
• For professional clinic use only, not suitable for home or self-administration

Who Should Avoid

• Patients with active scalp infections, open lesions, or unresolved dermatitis in the treatment area
• Pregnant or breastfeeding women: physician consultation required
• Individuals under 18 years of age
• Those with a known allergy or hypersensitivity to any component of the formulation
• Patients with autoimmune or blood-related conditions require medical clearance before starting treatment

 

5 FAQs

Why is the lyophilized format better than a liquid exosome product?

Liquid exosome products lose biological activity over time due to temperature fluctuations and protein degradation during storage. Lyophilization freeze-drying removes moisture under controlled conditions, effectively pausing biological activity until reconstitution. When mixed fresh at the time of treatment, ASCE+ HRLV exosomes are released at full potency, which is not something a pre-mixed liquid product can consistently guarantee.

How soon do patients see results?

Reduced shedding and improved scalp texture are typically noticeable within 3–4 weeks of starting treatment. Visible improvement in hair density and new growth usually becomes apparent after 2–3 completed sessions, with the most significant results building over the full recommended course of 4–6 sessions.

What does the IR52 Jang Young-sil Prize mean for this product?

The IR52 Jang Young-sil Prize is awarded by the South Korean government to products that demonstrate verifiable technological innovation. ExoCoBio receiving this award for the ASCE+ line in 2020 means the exosome technology behind HRLV has been independently evaluated and recognised as not a self-declared marketing claim.

Can ASCE+ HRLV be combined with other hair treatments?

Yes. It works well alongside PRP therapy, minoxidil protocols, and other scalp mesotherapy treatments as part of a multi-step hair restoration programme. Always coordinate combinations based on individual patient assessment and clinical judgment.

Is ASCE+ HRLV suitable for all types of hair loss?

It is particularly effective for androgenetic alopecia (male and female pattern), diffuse thinning, post-partum hair loss, and stress-induced shedding. Patients with scarring alopecia or complex dermatological scalp conditions should be assessed individually by a specialist before treatment begins.

Award-winning exosome science. 10 billion reasons to offer it.

Add ExoCoBio ASCE+ HRLV to your clinic and give your hair loss patients a treatment built on independently recognised Korean exosome technology.